Search - tctmd.com

Displaying 281 - 300 of 501

Sort: Relevancy | Date

Presentation TCT 2013

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

Presenter: Stephen Worthley

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

Presentation TCT 2013

Stenting of the Renal Artery: Avoiding and Treating Complications

Presenter: Michel Henry

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Medical Therapy: Still the First Choice

Presenter: Darrel Francis

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Presenter: Satya Reddy Atmakuri

October 28, 2013

Presentation TCT 2013

Didactic(5)

Presenter: Lynne Hinterbuchner

October 28, 2013

Presentation TCT 2013

Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation?

Presenter: Peter Fitzgerald

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Presenter: Paul Sobotka

October 27, 2013

Presentation TCT 2013

Selecting the Patient Most Likely to Benefit from Renal Artery Intervention

Presenter: Christopher White

October 27, 2013

Presentation TCT 2013

Renal Revascularization Data Review and Recommendations for Management

Presenter: Jeffrey Olin

October 27, 2013

Presentation TCT 2013

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Presenter: Justin Davies

October 27, 2013

Presentation TCT 2013

Reading the Tea Leaves: Possible Outcomes and Impact of the CORAL Trial

Presenter: Christopher Cooper

October 27, 2013

Presentation TCT 2013

Radiofrequency-Based RDN Is and Will Remain the Benchmark for RDN

Presenter: Meital Mazor

October 27, 2013

Presentation TCT 2013

Non-focused Ultrasound with the TIVUS Denervation Catheter for RDN

Presenter: Michael Jonas

October 27, 2013

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Advertisement

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Stenting of the Renal Artery: Avoiding and Treating Complications

Renal Denervation: Ready for Primetime?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Medical Therapy: Still the First Choice

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Didactic(5)

Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation?

The Spectrum of Current and Future Renal Denervation Clinical Trials

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Selecting the Patient Most Likely to Benefit from Renal Artery Intervention

Renal Revascularization Data Review and Recommendations for Management

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Reading the Tea Leaves: Possible Outcomes and Impact of the CORAL Trial

Radiofrequency-Based RDN Is and Will Remain the Benchmark for RDN

Non-focused Ultrasound with the TIVUS Denervation Catheter for RDN

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content